Loading...

SGMT SAGIMET BIOSCIENCES INC Capital Structure Changes 8-K Filing

SGMT

SGMT

SAGIMET BIOSCIENCES INC

(SGMT)

2025 8-K

Financial Results Update

Investor Update

New Stock Offering

Financial Results

Product Expansion

Financial Statements

Financial Results

Investor Update

Investor Update

Financial Results

Financial Results

Appointment of Directors

Update of Investor Presenta...

Amendment to Press Release

Annual Meeting and Clinical...

Update Presentation

Financial Results Announcement

Appointment of CFO

Financial Results and Board...

Appointment of Interim Prin...

Financial Condition Update

Update and Positive Trial R...

Departure of CFO

Equity Grants to Executive ...

Earnings Report

Presentation Update

Update and Press Release

Earnings Reports

Update Presentation

Appointment of CFO

External Links:

Sagimet Biosciences Inc. announced on August 14, 2025, a Sales Agreement to sell up to $75 million of its Series A common stock through Leerink Partners LLC. The previous sales agreement with Cantor Fitzgerald was terminated on the same date, without any shares sold under it.

AI Assistant

SAGIMET BIOSCIENCES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.